Global Respiratory Inhalers Market Growth (Status and Outlook) 2023-2029

Global Respiratory Inhalers Market Growth (Status and Outlook) 2023-2029

Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.

LPI (LP Information)' newest research report, the “Respiratory Inhalers Industry Forecast” looks at past sales and reviews total world Respiratory Inhalers sales in 2022, providing a comprehensive analysis by region and market sector of projected Respiratory Inhalers sales for 2023 through 2029. With Respiratory Inhalers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Inhalers industry.

This Insight Report provides a comprehensive analysis of the global Respiratory Inhalers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Respiratory Inhalers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Inhalers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Inhalers and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Inhalers.

The global Respiratory Inhalers market size is projected to grow from US$ 28170 million in 2022 to US$ 31050 million in 2029; it is expected to grow at a CAGR of 1.4% from 2023 to 2029.

Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Inhalers market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Dry Powder Inhaler
Metered Dose Inhaler
Others

Segmentation by application
Asthma
COPD
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.